<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract During the progression from" exact="hepatitis" post="to fibrosis, cirrhosis, and liver failure, the accumulation of"/>
 <result pre="liver inflammation is critical. The causes of hepatocyte injuries include" exact="viral hepatitis" post="infections, alcoholic hepatitis, and non-alcoholic fatty liver disease. Hepatocyte-derived"/>
 <result pre="inflammation is critical. The causes of hepatocyte injuries include viral" exact="hepatitis" post="infections, alcoholic hepatitis, and non-alcoholic fatty liver disease. Hepatocyte-derived"/>
 <result pre="critical. The causes of hepatocyte injuries include viral hepatitis infections," exact="alcoholic hepatitis," post="and non-alcoholic fatty liver disease. Hepatocyte-derived extracellular vesicles (Hep-EVs)"/>
 <result pre="hepatocyte injuries include viral hepatitis infections, alcoholic hepatitis, and non-alcoholic" exact="fatty liver disease." post="Hepatocyte-derived extracellular vesicles (Hep-EVs) released from stressed/damaged hepatocytes are"/>
 <result pre="injuries include viral hepatitis infections, alcoholic hepatitis, and non-alcoholic fatty" exact="liver disease." post="Hepatocyte-derived extracellular vesicles (Hep-EVs) released from stressed/damaged hepatocytes are"/>
 <result pre="vesicles (Hep-EVs) released from stressed/damaged hepatocytes are partly responsible for" exact="liver disease" post="progression and liver damage because they activate non-parenchymal cells"/>
 <result pre="potential diagnostic tools and novel therapeutic targets in patients with" exact="viral hepatitis," post="fatty liver steatosis, and alcoholic liver diseases. viral hepatitis"/>
 <result pre="with viral hepatitis, fatty liver steatosis, and alcoholic liver diseases." exact="viral hepatitis" post="non-alcoholic fatty liver disease alcoholic liver disease biomarkers extracellular"/>
 <result pre="viral hepatitis, fatty liver steatosis, and alcoholic liver diseases. viral" exact="hepatitis" post="non-alcoholic fatty liver disease alcoholic liver disease biomarkers extracellular"/>
 <result pre="fatty liver steatosis, and alcoholic liver diseases. viral hepatitis non-alcoholic" exact="fatty liver disease" post="alcoholic liver disease biomarkers extracellular vesicles microparticles exosomes 1."/>
 <result pre="liver steatosis, and alcoholic liver diseases. viral hepatitis non-alcoholic fatty" exact="liver disease" post="alcoholic liver disease biomarkers extracellular vesicles microparticles exosomes 1."/>
 <result pre="alcoholic liver diseases. viral hepatitis non-alcoholic fatty liver disease alcoholic" exact="liver disease" post="biomarkers extracellular vesicles microparticles exosomes 1. Introduction Chronic liver"/>
 <result pre="liver disease biomarkers extracellular vesicles microparticles exosomes 1. Introduction Chronic" exact="liver disease" post="is a major public health issue globally. It includes"/>
 <result pre="is a major public health issue globally. It includes chronic" exact="viral hepatitis," post="fatty liver disease, among other causes, and accounts for"/>
 <result pre="major public health issue globally. It includes chronic viral hepatitis," exact="fatty liver disease," post="among other causes, and accounts for approximately 3.5% of"/>
 <result pre="public health issue globally. It includes chronic viral hepatitis, fatty" exact="liver disease," post="among other causes, and accounts for approximately 3.5% of"/>
 <result pre="causes, and accounts for approximately 3.5% of deaths [1]. Viral" exact="hepatitis" post="is a persistent state of liver inflammation caused by"/>
 <result pre="inflammation caused by various viruses. It increases the risk of" exact="cirrhosis" post="and hepatocellular carcinoma (HCC). Chronic hepatitis B virus (CHB)"/>
 <result pre="by various viruses. It increases the risk of cirrhosis and" exact="hepatocellular carcinoma" post="(HCC). Chronic hepatitis B virus (CHB) and chronic hepatitis"/>
 <result pre="increases the risk of cirrhosis and hepatocellular carcinoma (HCC). Chronic" exact="hepatitis" post="B virus (CHB) and chronic hepatitis C virus (CHC)"/>
 <result pre="hepatocellular carcinoma (HCC). Chronic hepatitis B virus (CHB) and chronic" exact="hepatitis" post="C virus (CHC) infections are major risk factors for"/>
 <result pre="to 80% in various regional epidemics. In recent decades, non-alcoholic" exact="fatty liver disease" post="(NAFLD) and alcohol-associated liver disease have emerged as urgent"/>
 <result pre="80% in various regional epidemics. In recent decades, non-alcoholic fatty" exact="liver disease" post="(NAFLD) and alcohol-associated liver disease have emerged as urgent"/>
 <result pre="In recent decades, non-alcoholic fatty liver disease (NAFLD) and alcohol-associated" exact="liver disease" post="have emerged as urgent etiologies associated with an increasingly"/>
 <result pre="noting that the increase in non-alcoholic steatohepatitis (NASH) associated with" exact="obesity" post="and metabolic syndrome may have led, directly or indirectly,"/>
 <result pre="the increase in non-alcoholic steatohepatitis (NASH) associated with obesity and" exact="metabolic syndrome" post="may have led, directly or indirectly, to an increase"/>
 <result pre="(cccDNA) and pre-genomic RNA (pgRNA) formed during the replication of" exact="hepatitis" post="B virus (HBV). The assembly of proteins and nucleic"/>
 <result pre="Viral Hepatitis 2.1. Liquid Biopsies Associated Viral Hepatitis Infections Viral" exact="hepatitis" post="is an inflammation of the liver associated with infection"/>
 <result pre="an inflammation of the liver associated with infection by a" exact="hepatitis" post="virus. Researchers have debated whether viruses have infection strategies"/>
 <result pre="the surfaces of exosomes in numerous studies. This suggests that" exact="hepatitis" post="viruses may incorporate themselves into EVs during biogenesis to"/>
 <result pre="is a picornavirus—uses the host’s EV machinery to propagate enveloped" exact="hepatitis" post="A (eHAV); it comprises of two components: a nonenveloped"/>
 <result pre="solvent-insoluble membranes. This may hinder viral propagation. As with EVs," exact="hepatitis" post="C virus (HCV) targets are determined by multiple factors."/>
 <result pre="naive cells [25]. GB virus C (GBV-C), formally known as" exact="hepatitis" post="G virus (HGV), is a member of the Flaviviridae"/>
 <result pre="suggest that EVs play various functions in the pathogenesis of" exact="viral hepatitis" post="as shown in Figure 1. 2.2. Liquid Biopsies Associated"/>
 <result pre="that EVs play various functions in the pathogenesis of viral" exact="hepatitis" post="as shown in Figure 1. 2.2. Liquid Biopsies Associated"/>
 <result pre="evade immunity by protecting the HCV RNA from degradation. The" exact="hepatitis" post="A virus evades the human immune response by becoming"/>
 <result pre="HBV infection. Immune cell-derived circulating EVs are associated with advanced" exact="liver disease" post="and may be identified by microparticle markers of cell"/>
 <result pre="by Valpha24/Vbeta11 [32]. CHC patients can be identified among chronic" exact="hepatitis" post="patients by cell-derived EV biomarkers. The authors of another"/>
 <result pre="non-HCC patients [36]. A positive correlation among lncRNA-HULC, lncRNA-HEIH, and" exact="hepatitis" post="B X-interacting protein (HBXIP) indicated that hepatitis B X"/>
 <result pre="lncRNA-HULC, lncRNA-HEIH, and hepatitis B X-interacting protein (HBXIP) indicated that" exact="hepatitis" post="B X protein (HBx) may alter lncRNA expression, which"/>
 <result pre="linked to metabolic disorders including dyslipidemia, type 2 diabetes, and" exact="obesity" post="[50]. Various mechanisms contribute to the intrahepatic accumulation of"/>
 <result pre="higher in NAFLD patients and are not influenced by chronic" exact="hepatitis" post="[56]. Furthermore, there is a positive correlation between plasma"/>
 <result pre="discharged from damaged or stressed hepatic cells—exacerbate the progression of" exact="liver disease" post="through the stimulation of non-parenchymal cells [62]. In mouse"/>
 <result pre="patients and in patients with either or both of alcohol-related" exact="cirrhosis" post="and chronic hepatitis C-related cirrhosis [32,71]. Immature myeloid cells"/>
 <result pre="patients with either or both of alcohol-related cirrhosis and chronic" exact="hepatitis" post="C-related cirrhosis [32,71]. Immature myeloid cells (CD11b+, Ly6Chi, Ly6G-)"/>
 <result pre="either or both of alcohol-related cirrhosis and chronic hepatitis C-related" exact="cirrhosis" post="[32,71]. Immature myeloid cells (CD11b+, Ly6Chi, Ly6G-) have also"/>
 <result pre="increased proinflammatory markers (TNF-α, IL-1β, IL-6, and IL-12) [73]. Mouse" exact="obesity" post="models have been used to demonstrate that levels of"/>
 <result pre="Disease (ALD) 4.1. Biomarkers Associated Alcoholic Liver Disease (ALD) Alcoholic" exact="liver disease" post="(ALD) foreshadows a wide variety of liver pathologies from"/>
 <result pre="accompanied by inflammation; this eventually results in liver failure or" exact="cancer" post="[79]. ALD hepatitis is directly related to the toxic"/>
 <result pre="this eventually results in liver failure or cancer [79]. ALD" exact="hepatitis" post="is directly related to the toxic effects of alcohol."/>
 <result pre="that elevated levels of primary bile acids are associated with" exact="alcoholic hepatitis" post="(AH) [80]. Moratti et al. reported that increased plasma"/>
 <result pre="elevated levels of primary bile acids are associated with alcoholic" exact="hepatitis" post="(AH) [80]. Moratti et al. reported that increased plasma"/>
 <result pre="gamma (PTPRG) isoform sPTPRG in EVs excreted from the human" exact="hepatocellular carcinoma" post="cell line HepG2 are associated with alcohol-related hepatic injury"/>
 <result pre="mice model following chronic and binge alcohol consumption, and in" exact="alcoholic hepatitis" post="(AH) patients [82]. The summary of the liquid factors"/>
 <result pre="model following chronic and binge alcohol consumption, and in alcoholic" exact="hepatitis" post="(AH) patients [82]. The summary of the liquid factors"/>
 <result pre="Alcoholic Liver Disease (ALD) Investigations into EVs as biomarkers for" exact="alcoholic hepatitis" post="in humans have revealed increased levels of EVs in"/>
 <result pre="Liver Disease (ALD) Investigations into EVs as biomarkers for alcoholic" exact="hepatitis" post="in humans have revealed increased levels of EVs in"/>
 <result pre="hepatitis in humans have revealed increased levels of EVs in" exact="alcoholic hepatitis" post="patients and patients who consume excessive amounts of alcohol"/>
 <result pre="in humans have revealed increased levels of EVs in alcoholic" exact="hepatitis" post="patients and patients who consume excessive amounts of alcohol"/>
 <result pre="fragments M30 and M65 in EVs [90]. The severity of" exact="alcoholic hepatitis" post="is linked to EVs containing CD34+ and ASGPR+ [91]."/>
 <result pre="M30 and M65 in EVs [90]. The severity of alcoholic" exact="hepatitis" post="is linked to EVs containing CD34+ and ASGPR+ [91]."/>
 <result pre="that CD40L may stimulate the activation of macrophages in experimental" exact="alcoholic hepatitis" post="models [92]. Chemotaxis is the initiating step in neutrophil"/>
 <result pre="CD40L may stimulate the activation of macrophages in experimental alcoholic" exact="hepatitis" post="models [92]. Chemotaxis is the initiating step in neutrophil"/>
 <result pre="in both circulating and hepatic neutrophils, which are associated with" exact="alcoholic hepatitis" post="and disease aggression [94,95,96]. CXCL1 is an IL-8 homologue"/>
 <result pre="both circulating and hepatic neutrophils, which are associated with alcoholic" exact="hepatitis" post="and disease aggression [94,95,96]. CXCL1 is an IL-8 homologue"/>
 <result pre="they are implicated in complex networks of cell-to-cell communication in" exact="liver disease" post="development and progression. Some studies have presented analyses of"/>
 <result pre="and accurate approach to the diagnosis and monitoring of chronic" exact="liver disease." post="Acknowledgments The authors thank all authors for their publications"/>
 <result pre="decision to publish the results. Abbreviations ALT alanine transaminase AH" exact="alcoholic hepatitis" post="ALD alcoholic liver disease ASH alcoholic steatohepatitis cfDNA cell-free"/>
 <result pre="to publish the results. Abbreviations ALT alanine transaminase AH alcoholic" exact="hepatitis" post="ALD alcoholic liver disease ASH alcoholic steatohepatitis cfDNA cell-free"/>
 <result pre="results. Abbreviations ALT alanine transaminase AH alcoholic hepatitis ALD alcoholic" exact="liver disease" post="ASH alcoholic steatohepatitis cfDNA cell-free DNA CCL2 chemokine (C-C"/>
 <result pre="ligand 2 CXCL1 chemokine (C-X-C motif) ligand 1 CHB chronic" exact="hepatitis" post="B virus CHC chronic hepatitis C virus cccDNA covalently"/>
 <result pre="motif) ligand 1 CHB chronic hepatitis B virus CHC chronic" exact="hepatitis" post="C virus cccDNA covalently closed circular DNA dsDNA double-stranded"/>
 <result pre="vesicle GWAS genome-wide association study HSC hepatic stellate cell HAV" exact="hepatitis" post="A virus HBV hepatitis B virus HCV hepatitis C"/>
 <result pre="study HSC hepatic stellate cell HAV hepatitis A virus HBV" exact="hepatitis" post="B virus HCV hepatitis C virus HGV hepatitis G"/>
 <result pre="cell HAV hepatitis A virus HBV hepatitis B virus HCV" exact="hepatitis" post="C virus HGV hepatitis G virus HCC hepatocellular carcinoma"/>
 <result pre="virus HBV hepatitis B virus HCV hepatitis C virus HGV" exact="hepatitis" post="G virus HCC hepatocellular carcinoma Hcy homocysteine HuH human"/>
 <result pre="virus HCV hepatitis C virus HGV hepatitis G virus HCC" exact="hepatocellular carcinoma" post="Hcy homocysteine HuH human hepatocyte-derived carcinoma cell ILV intraluminal"/>
 <result pre="miRNA microRNA mtDNA mitochondrial DNA MVB multivesicular body NAFLD non-alcoholic" exact="fatty liver disease" post="NASH non-alcoholic steatohepatitis PA palmitic acid PBMC peripheral blood"/>
 <result pre="microRNA mtDNA mitochondrial DNA MVB multivesicular body NAFLD non-alcoholic fatty" exact="liver disease" post="NASH non-alcoholic steatohepatitis PA palmitic acid PBMC peripheral blood"/>
 <result pre="al.Early fibrosis but late tumor stage and worse outcomes in" exact="hepatocellular carcinoma" post="patients without hepatitis B or hepatitis CDig. Dis. Sci.201910.1007/s10620-019-05938-331722058"/>
 <result pre="tumor stage and worse outcomes in hepatocellular carcinoma patients without" exact="hepatitis" post="B or hepatitis CDig. Dis. Sci.201910.1007/s10620-019-05938-331722058 4.JunT.W.YehM.L.YangJ.D.ChenV.L.NguyenP.GiamaN.H.HuangC.F.HsingA.W.DaiC.Y.HuangJ.F.et al.More advanced"/>
 <result pre="worse outcomes in hepatocellular carcinoma patients without hepatitis B or" exact="hepatitis" post="CDig. Dis. Sci.201910.1007/s10620-019-05938-331722058 4.JunT.W.YehM.L.YangJ.D.ChenV.L.NguyenP.GiamaN.H.HuangC.F.HsingA.W.DaiC.Y.HuangJ.F.et al.More advanced disease and worse"/>
 <result pre="an envelope by hijacking cellular membranesNature201349636737110.1038/nature1202923542590 22.McKnightK.L.XieL.Gonzalez-LopezO.Rivera-SerranoE.E.ChenX.LemonS.M.Protein composition of the" exact="hepatitis" post="A virus quasi-envelopeProc. Natl. Acad. Sci. USA20171146587659210.1073/pnas.161951911428490497 23.NagashimaS.JirintaiS.TakahashiM.KobayashiT.TanggisNishizawaT.KoukiT.YashiroT.OkamotoH.Hepatitis E"/>
 <result pre="from multivesicular bodiesJ. Gen. Virol.2014952166217510.1099/vir.0.066910-024970738 24.LindenbachB.D.RiceC.M.The ins and outs of" exact="hepatitis" post="C virus entry and assemblyNat. Rev. Microbiol.20131168870010.1038/nrmicro309824018384 25.BukongT.N.Momen-HeraviF.KodysK.BalaS.SzaboG.Exosomes from"/>
 <result pre="hepatitis C virus entry and assemblyNat. Rev. Microbiol.20131168870010.1038/nrmicro309824018384 25.BukongT.N.Momen-HeraviF.KodysK.BalaS.SzaboG.Exosomes from" exact="hepatitis" post="C infected patients transmit HCV infection and contain replication"/>
 <result pre="in complex with Ago2-miR122-HSP90PLoS Pathog.201410e100442410.1371/journal.ppat.100442425275643 26.MeulemanP.HesselgesserJ.PaulsonM.VanwolleghemT.DesombereI.ReiserH.Leroux-RoelsG.Anti-CD81 antibodies can prevent a" exact="hepatitis" post="C virus infection in vivoHepatology2008481761176810.1002/hep.2254719030166 27.HarmanA.N.NasrN.FeethamA.GaloyanA.AlshehriA.A.RambukwelleD.BottingR.A.HienerB.M.DiefenbachE.DiefenbachR.J.et al.HIV blocks interferon"/>
 <result pre="Burden of Disease Liver Cancer CollaborationAkinyemijuT.AberaS.AhmedM.AlamN.AlemayohuM.A.AllenC.Al-RaddadiR.Alvis-GuzmanN.AmoakoY.et al.The burden of primary" exact="liver cancer" post="and underlying etiologies from 1990 to 2015 at the"/>
 <result pre="of Disease Liver Cancer CollaborationAkinyemijuT.AberaS.AhmedM.AlamN.AlemayohuM.A.AllenC.Al-RaddadiR.Alvis-GuzmanN.AmoakoY.et al.The burden of primary liver" exact="cancer" post="and underlying etiologies from 1990 to 2015 at the"/>
 <result pre="TGF-betaCell Mol. Gastroenterol. Hepatol.2016230231610.1016/j.jcmgh.2015.12.00528090562 31.FusegawaH.ShiraishiK.OgasawaraF.ShimizuM.HarukiY.MiyachiH.MatsuzakiS.AndoY.Platelet activation in patients with chronic" exact="hepatitis" post="CTokai J. Exp. Clin. Med.20022710110612713014 32.KornekM.LynchM.MehtaS.H.LaiM.ExleyM.AfdhalN.H.SchuppanD.Circulating microparticles as disease-specific"/>
 <result pre="as disease-specific biomarkers of severity of inflammation in patients with" exact="hepatitis" post="C or nonalcoholic steatohepatitisGastroenterology201214344845810.1053/j.gastro.2012.04.03122537612 33.LiJ.LiuK.LiuY.XuY.ZhangF.YangH.LiuJ.PanT.ChenJ.WuM.et al.Exosomes mediate the cell-to-cell"/>
 <result pre="IFN-alpha-induced antiviral activityNat. Immunol.20131479380310.1038/ni.264723832071 34.RamakrishnaiahV.ThumannC.FofanaI.HabersetzerF.PanQ.de RuiterP.E.WillemsenR.DemmersJ.A.Stalin RajV.JensterG.et al.Exosome-mediated transmission of" exact="hepatitis" post="C virus between human hepatoma Huh7.5 cellsProc. Natl. Acad."/>
 <result pre="hepatoma Huh7.5 cellsProc. Natl. Acad. Sci. USA2013110131091311310.1073/pnas.122189911023878230 35.SzaboG.Momen-HeraviF.Extracellular vesicles in" exact="liver disease" post="and potential as biomarkers and therapeutic targetsNat. Rev. Gastroenterol."/>
 <result pre="Med.20185647948410.1515/cclm-2017-032729252188 37.RuanL.HuangL.ZhaoL.WangQ.PanX.ZhangA.BaiQ.LvZ.The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in" exact="hepatitis" post="B patientsGastroenterol. Res. Pract.20182018918731610.1155/2018/918731630622563 38.LiuY.FengJ.SunM.YangG.YuanH.WangY.BuY.ZhaoM.ZhangS.ZhangX.Long non-coding RNA HULC activates"/>
 <result pre="the MICA promoter which regulates MICA expression and increases HCV-related" exact="hepatocellular carcinoma" post="riskPLoS ONE20138e6127910.1371/journal.pone.006127923593449 41.HuangC.F.WangS.C.YehM.L.HuangC.I.TsaiP.C.LinZ.Y.ChenS.C.DaiC.Y.HuangJ.F.ChuangW.L.et al.Association of serial serum major histocompatibility"/>
 <result pre="serum major histocompatibility complex class I chain-related A measurements with" exact="hepatocellular carcinoma" post="in chronic hepatitis C patients after viral eradicationJ. Gastroenterol."/>
 <result pre="class I chain-related A measurements with hepatocellular carcinoma in chronic" exact="hepatitis" post="C patients after viral eradicationJ. Gastroenterol. Hepatol.20193424925510.1111/jgh.1435929932235 42.HuangC.F.WangS.C.ChangW.T.YehM.L.HuangC.I.LinZ.Y.ChenS.C.ChuangW.L.HuangJ.F.DaiC.Y.et al.Lower"/>
 <result pre="expression levels of MHC class I chain-related gene A in" exact="hepatocellular carcinoma" post="are at high risk of recurrence after surgical resectionSci."/>
 <result pre="cell-free DNA as a predictive marker for distant metastasis of" exact="hepatitis" post="C virus-related hepatocellular carcinomaBr. J. Cancer2007971399140310.1038/sj.bjc.660403417940509 47.IidaM.IizukaN.SakaidaI.MoribeT.FujitaN.MiuraT.TamatsukuriS.IshitsukaH.UchidaK.TeraiS.et al.Relation between"/>
 <result pre="between serum levels of cell-free DNA and inflammation status in" exact="hepatitis" post="C virus-related hepatocellular carcinomaOncol. Rep.20082076176518813815 48.NgC.K.Y.Di CostanzoG.G.TerraccianoL.M.PiscuoglioS.Circulating cell-free DNA"/>
 <result pre="Rev.201645778610.1016/j.ctrv.2016.02.00826995632 52.YangR.X.HuC.X.SunW.L.PanQ.ShenF.YangZ.SuQ.XuG.W.FanJ.G.Serum monounsaturated triacylglycerol predicts steatohepatitis in patients with non-alcoholic" exact="fatty liver disease" post="and chronic hepatitis BSci. Rep.201771051710.1038/s41598-017-11278-x28874844 53.FartouxL.ChazouillèresO.WendumD.PouponR.SerfatyL.Impact of steatosis on"/>
 <result pre="52.YangR.X.HuC.X.SunW.L.PanQ.ShenF.YangZ.SuQ.XuG.W.FanJ.G.Serum monounsaturated triacylglycerol predicts steatohepatitis in patients with non-alcoholic fatty" exact="liver disease" post="and chronic hepatitis BSci. Rep.201771051710.1038/s41598-017-11278-x28874844 53.FartouxL.ChazouillèresO.WendumD.PouponR.SerfatyL.Impact of steatosis on"/>
 <result pre="steatohepatitis in patients with non-alcoholic fatty liver disease and chronic" exact="hepatitis" post="BSci. Rep.201771051710.1038/s41598-017-11278-x28874844 53.FartouxL.ChazouillèresO.WendumD.PouponR.SerfatyL.Impact of steatosis on progression of fibrosis"/>
 <result pre="of steatosis on progression of fibrosis in patients with mild" exact="hepatitis" post="CHepatology200541828710.1002/hep.2051915690484 54.MehtaS.R.ThomasE.L.BellJ.D.JohnstonD.G.Taylor-RobinsonS.D.Non-invasive means of measuring hepatic fat contentWorld J."/>
 <result pre="diseaseGut2017661321132810.1136/gutjnl-2016-31152627002005 56.De CarvalhoS.C.MunizM.T.SiqueiraM.D.SiqueiraE.R.GomesA.V.SilvaK.A.BezerraL.C.D’AlmeidaV.de OliveiraC.P.PereiraL.M.Plasmatic higher levels of homocysteine in non-alcoholic" exact="fatty liver disease" post="(NAFLD)Nutr. J.2013123710.1186/1475-2891-12-3723547829 57.GulsenM.YesilovaZ.BagciS.UygunA.OzcanA.ErcinC.N.ErdilA.SanisogluS.Y.CakirE.AtesY.et al.Elevated plasma homocysteine concentrations as a"/>
 <result pre="56.De CarvalhoS.C.MunizM.T.SiqueiraM.D.SiqueiraE.R.GomesA.V.SilvaK.A.BezerraL.C.D’AlmeidaV.de OliveiraC.P.PereiraL.M.Plasmatic higher levels of homocysteine in non-alcoholic fatty" exact="liver disease" post="(NAFLD)Nutr. J.2013123710.1186/1475-2891-12-3723547829 57.GulsenM.YesilovaZ.BagciS.UygunA.OzcanA.ErcinC.N.ErdilA.SanisogluS.Y.CakirE.AtesY.et al.Elevated plasma homocysteine concentrations as a"/>
 <result pre="liver and adipose tissue of mice with high fat diet-induced" exact="obesity" post="and nonalcoholic fatty liver diseaseEur. J. Gastroenterol. Hepatol.20082084385410.1097/MEG.0b013e3282f9b20318794597 61.YoshidaM.Novel"/>
 <result pre="nonalcoholic fatty liver diseaseCurr. Gastroenterol. Rep.20057323610.1007/s11894-005-0063-415701296 80.TrinchetJ.C.GerhardtM.F.BalkauB.MunzC.PouponR.E.Serum bile acids and" exact="cholestasis" post="in alcoholic hepatitis. Relationship with usual liver tests and"/>
 <result pre="liver diseaseCurr. Gastroenterol. Rep.20057323610.1007/s11894-005-0063-415701296 80.TrinchetJ.C.GerhardtM.F.BalkauB.MunzC.PouponR.E.Serum bile acids and cholestasis in" exact="alcoholic hepatitis." post="Relationship with usual liver tests and histological featuresJ. Hepatol.19942123524010.1016/S0168-8278(05)80401-57989715"/>
 <result pre="reticulum stressHepatol. Commun.2017167569010.1002/hep4.106629404485 85.BodeC.KuglerV.BodeJ.C.Endotoxemia in patients with alcoholic and non-alcoholic" exact="cirrhosis" post="and in subjects with no evidence of chronic liver"/>
 <result pre="non-alcoholic cirrhosis and in subjects with no evidence of chronic" exact="liver disease" post="following acute alcohol excessJ. Hepatol.1987481410.1016/S0168-8278(87)80003-X3571935 86.CaiY.XuM.J.KoritzinskyE.H.ZhouZ.WangW.CaoH.YuenP.S.RossR.A.StarR.A.LiangpunsakulS.et al.Mitochondrial DNA-enriched microparticles"/>
 <result pre="and hepatotoxicityJCI Insight201729263410.1172/jci.insight.9263428724791 87.SahaB.Momen-HeraviF.FuriI.KodysK.CatalanoD.GangopadhyayA.HarasztiR.SatishchandranA.Iracheta-VellveA.AdejumoA.et al.Extracellular vesicles from mice with alcoholic" exact="liver disease" post="carry a distinct protein cargo and induce macrophage activation"/>
 <result pre="infiltration in alcoholic hepatitisAlcohol200227172110.1016/S0741-8329(02)00206-912062632 95.DominguezM.MiquelR.ColmeneroJ.MorenoM.García-PagánJ.C.BoschJ.ArroyoV.GinèsP.CaballeríaJ.BatallerR.Hepatic expression of CXC chemokines predicts" exact="portal hypertension" post="and survival in patients with alcoholic hepatitisGastroenterology20091361639165010.1053/j.gastro.2009.01.05619208360 96.SheronN.BirdG.KoskinasJ.PortmannB.CeskaM.LindleyI.WilliamsR.Circulating and"/>
 <result pre="of the neutrophil chemotaxin interleukin-8 are elevated in severe acute" exact="alcoholic hepatitis," post="and tissue levels correlate with neutrophil infiltrationHepatology19931841468325620 97.RohY.S.ZhangB.LoombaR.SekiE.TLR2 and"/>
 <result pre="1 Summary of the viral liquid biopsy markers driven by" exact="hepatitis" post="viruses in the pathogenesis of viral hepatitis. Classification of"/>
 <result pre="biopsy markers driven by hepatitis viruses in the pathogenesis of" exact="viral hepatitis." post="Classification of viral related liquid biopsies by viral infection"/>
 <result pre="of the liquid factors associated with liver inflammation in Alcoholic" exact="liver disease" post="(ALD). Figure 4 The potential of the liquid biopsy"/>
 <result pre="and accurate approach to the diagnosis and monitoring of chronic" exact="liver disease" post="by disease associated markers from EVs, cfDNA, and serum"/>
 <result pre="efficiency in the future. ijms-21-03732-t001_Table 1Table 1 Liquid biomarkers of" exact="viral hepatitis" post="liver diseases. References Biomarker Type of Liquid Biopsy Application"/>
 <result pre="in the future. ijms-21-03732-t001_Table 1Table 1 Liquid biomarkers of viral" exact="hepatitis" post="liver diseases. References Biomarker Type of Liquid Biopsy Application"/>
 <result pre="DNA (cfDNA); covalently closed circular DNA (cccDNA); extracellular vesicle (EV);" exact="hepatitis" post="A virus (HAV); hepatitis B virus (HBV); hepatitis C"/>
 <result pre="circular DNA (cccDNA); extracellular vesicle (EV); hepatitis A virus (HAV);" exact="hepatitis" post="B virus (HBV); hepatitis C virus (HCV); hepatitis G"/>
 <result pre="vesicle (EV); hepatitis A virus (HAV); hepatitis B virus (HBV);" exact="hepatitis" post="C virus (HCV); hepatitis G virus (HGV); human hepatocyte-derived"/>
 <result pre="virus (HAV); hepatitis B virus (HBV); hepatitis C virus (HCV);" exact="hepatitis" post="G virus (HGV); human hepatocyte-derived carcinoma cells (HuH); intraluminal"/>
 <result pre="vesicles (EVs); cytochrome P450 2E1 (CYP2E1); mitochondrial DNA (mtDNA); non-alcoholic" exact="fatty liver disease" post="(NAFLD); non-alcoholic steatohepatitis (NASH); peroxisome proliferator-activated receptor gamma (PPARγ);"/>
 <result pre="(EVs); cytochrome P450 2E1 (CYP2E1); mitochondrial DNA (mtDNA); non-alcoholic fatty" exact="liver disease" post="(NAFLD); non-alcoholic steatohepatitis (NASH); peroxisome proliferator-activated receptor gamma (PPARγ);"/>
 <result pre="homocysteine (Hcy); cytochrome P450 2E1 (CYP2E1); mitochondrial DNA (mtDNA); non-alcoholic" exact="fatty liver disease" post="(NAFLD); non-alcoholic steatohepatitis (NASH); peroxisome proliferator-activated receptor gamma (PPARγ);"/>
 <result pre="(Hcy); cytochrome P450 2E1 (CYP2E1); mitochondrial DNA (mtDNA); non-alcoholic fatty" exact="liver disease" post="(NAFLD); non-alcoholic steatohepatitis (NASH); peroxisome proliferator-activated receptor gamma (PPARγ);"/>
 <result pre="tyrosine phosphatase receptor gamma extracellular domain (sPTPRG); Alanine transaminase (ALT);" exact="alcoholic hepatitis" post="(AH); alcoholic liver disease (ALD); alcoholic steatohepatitis (ASH); chemokine"/>
 <result pre="phosphatase receptor gamma extracellular domain (sPTPRG); Alanine transaminase (ALT); alcoholic" exact="hepatitis" post="(AH); alcoholic liver disease (ALD); alcoholic steatohepatitis (ASH); chemokine"/>
 <result pre="extracellular domain (sPTPRG); Alanine transaminase (ALT); alcoholic hepatitis (AH); alcoholic" exact="liver disease" post="(ALD); alcoholic steatohepatitis (ASH); chemokine (C-C motif) ligand 2"/>
</results>
